In the News
By Henry Rodgers and Dylan Housman, May 12, 2021
Republicans in Congress are introducing two new bills to combat what they call the “job-killing Biden agenda.”
by: Mackenzie Moore, WJHL
Posted: May 12, 2021 / 03:53 PM EDT
Congresswoman Diana Harshbarger (R-Tenn.) has introduced new legislation that would reform occupational licensing regulations.
With the support of the Republican Study Committee, Harshbarger introduced the Freedom to Work Act to encourage states and the federal government to roll back on these legislations.
By HANK HAYES, May 3, 2021
U.S. Rep. Diana Harshbarger has announced the First District’s winning entry in the 2021 Congressional Art Competition.
“I would like to congratulate Luke Pennington on winning Tennessee’s First District spot in the Congressional Art Competition,” Harshbarger said in a press release.
By Congresswoman Diana Harshbarger
I visited the Rio Grande Valley sector of our southern border near McAllen, Texas, along with colleagues from the House Homeland Security Committee to see the national security, humanitarian and public health border crisis for myself.
by: Ashley Sharp
Posted: Apr 14, 2021 / 06:49 PM EDT / Updated: Apr 14, 2021 / 08:12 PM EDT
Tennessee Rep. Diana Harshbarger is back in D.C. after visiting the U.S.-Mexico border.
The Republican representing Tennessee’s First Congressional District met with Border Patrol agents on the crisis they are now dealing with as more migrants flee countries like Mexico, Guatemala and Honduras to find refuge the U.S.
by: Slater Teague
Posted: Mar 11, 2021 / 10:06 PM EST / Updated: Mar 11, 2021 / 10:06 PM EST
Rep. Diana Harshbarger has introduced her first bill, legislation that she says could lead to lower prescription drug costs. To read the article, visit here.
by: Slater Teague
Posted: Mar 11, 2021 / 03:34 PM EST / Updated: Mar 11, 2021 / 03:34 PM EST
Rep. Diana Harshbarger voted against two Democratic efforts to expand background check requirements for firearms sales. Click here to read the full article.
by: Slater Teague
WASHINGTON (WJHL) — Neopharma’s pharmaceutical manufacturing facility in Bristol will keep its critical infrastructure designation even after the COVID-19 pandemic is over.







